ISPOR 2022

Oxford University Innovation's Clinical Outcome team will be attending the annual ISPOR 2022 conference in Washington, DC, USA from the 15th - 18th May 2022.

Read more

PDQ-39 used to evaluate Health-Related Quality of Life in randomized controlled trial that uses DBS system to treat patients with Parkinson’s disease

Patients were implanted bilaterally with Boston Scientific’s FDA-approved Vercise Genus DBS system. During long-term follow-up, quality of life was evaluated using the Parkinson’s Disease Questionnaire (PDQ-39).

Read more

Oxford Cognitive Screen is now available as a cultural adaption for Australia!

Read more

Call for Abstracts – National PROMs Annual Research Conference, 14th and 15th June 2022

Read more

Measure the quality of patient recovery following surgery & anaesthesia with real-time feedback through the use of PostopQRS™

A new web-based digital e(COA) tool now available from the Clinical Outcomes team at Oxford University Innovation.

Read more

Save the date – National PROMs Annual Research Conference, 14th and 15th June 2022

Read more

Generate QALY’s for use in analysis of mental healthcare interventions

Recovering Quality of Life - Utility Index now available! Health economists can now build Quality-Adjusted Life Year (QALY) evidence in support of their mental healthcare interventions.

Read more

ReQoL-10 Visualisation Tool – available online

Read more

User News: The Endometriosis Health Profile (EHP) used to gather evidence in clinical trial of improved Quality of Life (QoL) in women with Endometriosis-associated pain

The Endometriosis Health Profile (EHP)-30 successfully employed as part of a Randomized Control Trial to assess whether O-118 - Reglugolix combination therapy improves multiple dimensions of quality of life in women with Endometriosis-associated pain.

Read more